3i Fund provides Cerenome with up to $20m senior secured facility
The Houston CNS oncology company will use the royalty-based financing to scale its CNSide cerebrospinal fluid assay and said cash runway now extends into 2028.
1 min read11 Sept 2026Read all of the latest venture debt news and growth debt news from across the global growth lending market. Including fund closes, new deals and other market news.
The Houston CNS oncology company will use the royalty-based financing to scale its CNSide cerebrospinal fluid assay and said cash runway now extends into 2028.
1 min read11 Sept 2026The facility refinances the construction loan on the Washington e-SAF plant and will fund expansion including additional hydrogen capacity.
1 min read11 Sept 2026Proceeds will advance clinical development of ETH47 for asthma and COPD and related respiratory mRNA programmes, including mucosal influenza vaccine candidates.
1 min read10 Sept 2026The California power electronics company also appointed former Tesla chief financial officer Zach Kirkhorn to its board as it scales Factory One production.
1 min read10 Sept 2026Proceeds will support commercial expansion of the NEUROMARK System and sales and marketing investment after a €62.5m Series C earlier this year.
1 min read9 Sept 2026The Mexico City lender will use the capital to accelerate product innovation and expand across Mexico, the United States and other markets.
1 min read9 Sept 2026The milestone follows equity commitments into Hercules Growth Lending IV and the inaugural perpetual Hercules Evergreen Fund, alongside a rated note offering.
1 min read9 Sept 2026Proceeds will fund higher marketing spend on proven cohorts across the studio’s consumer apps and AI products.
1 min read8 Sept 2026Companies House lists Gilion Credit I AB as chargeholder on a filing created and delivered on 10 June 2026.
1 min read8 Sept 2026The total comprises €440m of fund commitments and €135m of affiliated discretionary mandates, ahead of a €500m target.
1 min read7 Sept 2026